ArticleNucleic acids research2020
Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort.
Abstract readPublished Erratum
In one paragraph
Article in Nucleic acids research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Two-hit events occurred independently in bilateral breast cancers in a germline double heterozygous carrier for BRCA1 and BRCA2.Breast cancer (Tokyo, Japan) · 2025Article
- Improved modeling of RNA-binding protein motifs in an interpretable neural model of RNA splicing.Genome biology · 2024Article
- Gastric Juvenile Polyposis with Intramucosal Cancer Diagnosed by Magnifying Endoscopy with Narrow-band Imaging.Internal medicine (Tokyo, Japan) · 2023Article
- Interpretable prioritization of splice variants in diagnostic next-generation sequencing.American journal of human genetics · 2021Article
- Article
Corrections and comments
- Erratum for
Authors and funding
34 authors.
Raphaël LemanLaboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.
Pascaline GaildratInserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Gérald Le GacInserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Chandran KaInserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Yann FichouInserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Marie-Pierre AudrezetInserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Virginie Caux-MoncoutierInserm U830, Institut Curie Centre de Recherches, 75005 Paris, France.
Sandrine M CaputoService de Génétique, Institut Curie, 75005 Paris, France.
Nadia Boutry-KryzaUnité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon, 69000 Lyon, France.
Mélanie LéoneUnité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon, 69000 Lyon, France.
Sylvie MazoyerLyon Neuroscience Research Center-CRNL, Inserm U1028, CNRS UMR 5292, University of Lyon, 69008 Lyon, France.
Françoise Bonnet-DorionInserm U916, Département de Pathologie, Laboratoire de Génétique Constitutionnelle, Institut Bergonié, 33000 Bordeaux, France.
Nicolas SevenetInserm U916, Département de Pathologie, Laboratoire de Génétique Constitutionnelle, Institut Bergonié, 33000 Bordeaux, France.
Marine Guillaud-BatailleGustave Roussy, Université Paris-Saclay, Département de Biopathologie, 94805 Villejuif, France.
Etienne RouleauGustave Roussy, Université Paris-Saclay, Département de Biopathologie, 94805 Villejuif, France.
Brigitte Bressac-de PailleretsGustave Roussy, Université Paris-Saclay, Département de Biopathologie, 94805 Villejuif, France.
Barbara WappenschmidtDivision of Molecular Gynaeco-Oncology, Department of Gynaecology and Obstetrics, University Hospital of Cologne, 50937 Cologne, Germany.
Maria RossingCentre for Genomic Medicine, Rigshospitalet, University of Copenhagen, 1017 Copenhagen, Denmark.
Danielle MullerLaboratoire d'Oncogénétique, Centre Paul Strauss, 67000 Strasbourg, France.
Violaine BourdonLaboratoire d'Oncogénétique Moléculaire, Institut Paoli-Calmettes, 13009 Marseille, France.
Françoise RevillonLaboratoire d'Oncogénétique Moléculaire Humaine, Centre Oscar Lambret, 59000 Lille, France.
Michael T ParsonsDepartment of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, 4006 Herston, Queensland, Australia.
Antoine RousselinLaboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.
Grégoire DavyLaboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.
Gaia CastelainInserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Laurent CastéraLaboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.
Joanna SokolowskaService de Génétique, CHU Nancy, 54035 Nancy, France.
Florence CouletService de génétique, Hôpital Pitié Salpétrière, AP-HP, 75013 Paris, France.
Capucine DelnatteLaboratoire de génétique moléculaire, CHU Nantes, 44000 Nantes, France.
Claude FérecInserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, 29200 Brest, France.
Amanda B SpurdleDepartment of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, 4006 Herston, Queensland, Australia.
Alexandra MartinsInserm U1245 Genomics and Personalized Medecine in Cancer and Neurological Disorders, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, 76031 Rouen, France.
Sophie KriegerLaboratoire de Biologie Clinique et Oncologique, Centre François Baclesse, 14000 Caen, France.
Claude HoudayerInserm U830, Institut Curie Centre de Recherches, 75005 Paris, France.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.